109 filings
Page 4 of 6
8-K
2gc91i cmuosjtznm
25 Mar 19
Departure of Directors or Certain Officers
4:08pm
8-K
hvvtglg2
27 Feb 19
CytomX Therapeutics Announces Full-Year 2018 Financial Results
12:00am
8-K
kld f1n0zrnr
26 Feb 19
Regulation FD Disclosure
7:36am
8-K
ie9mi lowx82lg
31 Jan 19
Departure of Directors or Certain Officers
4:06pm
8-K
dts6g fz8
20 Dec 18
CytomX Therapeutics Announces Changes to its Board of Directors
8:06am
8-K
qp8vn0o4
6 Nov 18
CytomX Therapeutics Announces Third Quarter 2018 Financial Results
4:07pm
8-K
e33i8zbj0ngar
22 Oct 18
Regulation FD Disclosure
7:30am
8-K
sxgov3dinv nrbf6xy
8 Aug 18
CytomX Therapeutics Announces Second Quarter 2018 Financial Results
4:06pm
8-K
kpcyisg b02nyir2kkcm
17 Jul 18
Other Events
4:10pm
8-K
bq57yfd4
10 Jul 18
Results of Operations and Financial Condition
4:06pm
8-K
c7jhgcfwpmc5l3
15 Jun 18
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
7xbzs0ag1kil78dcwf
4 Jun 18
Other Events
12:00am
8-K
4wq78t9mwqqw1 xpdpq
22 May 18
Other Events
7:36am
8-K
dxnqfjfq62 4zd
16 May 18
Regulation FD Disclosure
5:02pm
8-K
n2fc66qq
9 May 18
CytomX Therapeutics Announces First Quarter 2018 Financial Results
4:05pm
8-K
pymmke5x
7 Mar 18
CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update
12:00am
8-K
2ir8bt2fjxmjsr8 nof
29 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
u6hjpg
8 Jan 18
Regulation FD Disclosure
12:00am
8-K
j35xxkrv 4gurtpvu
4 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
b7r1y6
28 Nov 17
CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody Therapeutic
12:00am